Keyword: Stada Arzneimittel
Perrigo is looking toward some M&A, with its eye on the consumer health business that Germany’s Merck KGaA has put on the auction block.
Last week, an activist investor held out on the buyout offer for Stada—and it worked.
Hoping to land on its feet after a tough year, Stada will soon be under new leadership.
Two weeks after their bid failed to garner key support from shareholders, Stada’s wannabe buyers are back.
In the wake of last week's canceled buyout, Stada's CEO and CFO have left the company, and new buyout talk has already sprung up.
Weeks after announcing a €5.32 billion ($5.63 billion) buyout, German generics maker Stada said the deal failed to get shareholder approval.
German drugmaker Stada has announced plans to sell itself for €5.32 billion ($5.63 billion) shortly after weighing a $3.7 billion private equity takeout.
After an M&A downturn in 2016, industry watchers have been hoping for a resurgence. But so far this year, deal activity has slowed even more.
Amid a flurry of deal action for German drugmaker Stada, local media report that CEO Matthias Wiedenfels was targeted in a spying operation.